Drug intelligence / Profile preview

GYNSKILL

Development stage
Preclinical
Lead developer
Bioscience Institute
Modality
Stem Cell Therapies → Cell Therapies
Administration
Vaginal
01

Overview

GYNSKILL (also referred to as GynSkill) is an autologous adipose-derived stem cell (ADSC) therapy developed by the Bioscience Institute for vulvovaginal rejuvenation and the treatment of conditions such as postmenopausal vaginal atrophy, vaginal dryness, flaccidity, urinary incontinence, lichen sclerosus of the vulvar region, and female sexual dysfunction. The procedure involves harvesting a small fat sample (approximately 20 cc) from the patient, from which mesenchymal stem cells (MSCs) are isolated, expanded in vitro, and subsequently injected into the vulvovaginal tissues. Once administered, these expanded stem cells release various regenerative growth factors, promote mucosal repair and vascularization, and stimulate the synthesis of collagen and elastin to restore tissue elasticity, moisture, and physiological function.

Brand names
GYNSKILL
Other names
GynSkill

Beyond the preview

Go deeper on GYNSKILL.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on GYNSKILL.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call